FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

28995111000001107: Mintreleq XL 200mg tablets (CEB Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
91088701000001114 Mintreleq XL 200mg tablets (CEB Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
103770101000001114 Mintreleq XL 200mg tablets (Aristo Pharma Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mintreleq XL 200mg tablets (CEB Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mintreleq XL 200mg tablets (CEB Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mintreleq XL 200mg tablets (CEB Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Mintreleq XL 200mg tablets (CEB Pharma Ltd) Is a Product containing precisely quetiapine (as quetiapine fumarate) 200 milligram/1 each prolonged-release oral tablet true Inferred relationship Existential restriction modifier
Mintreleq XL 200mg tablets (CEB Pharma Ltd) Has active ingredient Quetiapine false Inferred relationship Existential restriction modifier
Mintreleq XL 200mg tablets (CEB Pharma Ltd) Has manufactured dose form Extended-release tablet false Inferred relationship Existential restriction modifier
Mintreleq XL 200mg tablets (CEB Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mintreleq XL 200mg tablets (CEB Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mintreleq XL 200mg tablets (CEB Pharma Ltd) Has specific active ingredient Quetiapine fumarate true Inferred relationship Existential restriction modifier
Mintreleq XL 200mg tablets (CEB Pharma Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Mintreleq XL 200mg tablets (CEB Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Quetiapine true Inferred relationship Existential restriction modifier
Mintreleq XL 200mg tablets (CEB Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Mintreleq XL 200mg tablets (CEB Pharma Ltd) Is a Mintreleq XL true Inferred relationship Existential restriction modifier
Mintreleq XL 200mg tablets (CEB Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mintreleq XL 200mg tablets (CEB Pharma Ltd) Has basis of strength substance Quetiapine true Inferred relationship Existential restriction modifier
Mintreleq XL 200mg tablets (CEB Pharma Ltd) Has manufactured dose form Prolonged-release oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mintreleq XL 200mg tablets (CEB Pharma Ltd) 60 tablet 6 x 10 tablets Has AMP True Mintreleq XL 200mg tablets (CEB Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start